Baird Financial Group
HOLX

Baird Financial Group’s Hologic HOLX Stock Holding History

Baird Financial Group’s Portfolio HOLX Stock Details HOLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-18,492
Closed -$1.4M – 1948
2026
Q1 		$1.4M Buy
18,492
+1,397
+8% +$105K ﹤0.01% 1163
2025
Q4 		$1.27M Sell
17,095
-19,034
-53% -$1.39M ﹤0.01% 1171
2025
Q3 		$2.44M Buy
36,129
+17,246
+91% +$1.14M ﹤0.01% 979
2025
Q2 		$1.23M Sell
18,883
-1,286
-6% -$77.1K ﹤0.01% 1157
2025
Q1 		$1.25M Sell
20,169
-47,449
-70% -$3.14M ﹤0.01% 1103
2024
Q4 		$4.87M Buy
67,618
+1,892
+3% +$148K 0.01% 683
2024
Q3 		$5.35M Buy
65,726
+46,194
+237% +$3.69M 0.01% 658
2024
Q2 		$1.45M Sell
19,532
-754
-4% -$56.5K ﹤0.01% 1051
2024
Q1 		$1.58M Sell
20,286
-85,239
-81% -$6.34M ﹤0.01% 1019
2023
Q4 		$7.54M Sell
105,525
-5,363
-5% -$373K 0.02% 542
2023
Q3 		$7.7M Buy
110,888
+94,076
+560% +$7.11M 0.02% 501
2023
Q2 		$1.36M Sell
16,812
-108,069
-87% -$8.83M ﹤0.01% 1019
2023
Q1 		$10.1M Sell
124,881
-28,415
-19% -$2.29M 0.02% 427
2022
Q4 		$11.5M Sell
153,296
-8,992
-6% -$640K 0.03% 404
2022
Q3 		$10.5M Buy
162,288
+9,197
+6% +$637K 0.03% 414
2022
Q2 		$10.6M Buy
153,091
+119,686
+358% +$8.88M 0.03% 423
2022
Q1 		$2.57M Buy
33,405
+13,486
+68% +$970K 0.01% 806
2021
Q4 		$1.52M Buy
19,919
+3,835
+24% +$282K ﹤0.01% 1040
2021
Q3 		$1.19M Sell
16,084
-7,642
-32% -$573K ﹤0.01% 1138
2021
Q2 		$1.58M Sell
23,726
-1,927
-8% -$129K ﹤0.01% 1009
2021
Q1 		$1.91M Buy
25,653
+7,721
+43% +$586K 0.01% 903
2020
Q4 		$1.31M Sell
17,932
-389
-2% -$27.5K ﹤0.01% 919
2020
Q3 		$1.22M Buy
18,321
+3,464
+23% +$219K ﹤0.01% 891
2020
Q2 		$847K Buy
14,857
+26
+0.2% +$1.28K ﹤0.01% 979
2020
Q1 		$521K Buy
14,831
+242
+2% +$11.5K ﹤0.01% 1049
2019
Q4 		$762K Sell
14,589
-961
-6% -$47.8K ﹤0.01% 1048
2019
Q3 		$785K Buy
15,550
+669
+4% +$32.9K ﹤0.01% 1040
2019
Q2 		$715K Buy
14,881
+228
+2% +$10.5K ﹤0.01% 1094
2019
Q1 		$709K Hold
14,653
– – ﹤0.01% 949
2018
Q4 		$602K Buy
14,653
+4,593
+46% +$188K ﹤0.01% 931
2018
Q3 		$413K Sell
10,060
-3,103
-24% -$125K ﹤0.01% 1096
2018
Q2 		$523K Sell
13,163
-264
-2% -$10.2K ﹤0.01% 996
2018
Q1 		$502K Hold
13,427
– – ﹤0.01% 1014
2017
Q4 		$574K Buy
13,427
+198
+1% +$7.9K ﹤0.01% 968
2017
Q3 		$485K Buy
13,229
+2,969
+29% +$120K ﹤0.01% 997
2017
Q2 		$466K Sell
10,260
-150
-1% -$6.62K ﹤0.01% 980
2017
Q1 		$443K Hold
10,410
– – ﹤0.01% 980
2016
Q4 		$418K Hold
10,410
– – ﹤0.01% 968
2016
Q3 		$404K Hold
10,410
– – ﹤0.01% 982
2016
Q2 		$360K Sell
10,410
-262
-2% -$9.07K ﹤0.01% 1005
2016
Q1 		$368K Buy
10,672
+108
+1% +$3.77K ﹤0.01% 999
2015
Q4 		$409K Buy
10,564
+66
+0.6% +$2.57K ﹤0.01% 976
2015
Q3 		$411K Sell
10,498
-3,501
-25% -$139K ﹤0.01% 975
2015
Q2 		$533K Buy
+13,999
New +$490K 0.01% 939

Other funds holding HOLX

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Baird Financial Group's HOLX Position: Q2 2026 in Review

Baird Financial Group sold out of Hologic (HOLX) in Q2 2026, closing a stake of 18,492 shares — an estimated $1.4M sold.

Baird Financial Group first reported a position in HOLX in Q2 2015 and held it in 44 quarters. The position peaked at $11.5M in Q4 2022. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.

  • Baird Financial Group reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
  • Baird Financial Group sold 18,492 Hologic shares in Q2 2026, an estimated $1.4M.
  • Baird Financial Group first reported a position in Hologic in Q2 2015 and held it in 44 quarters.
  • Baird Financial Group's Hologic position peaked at $11.5M in Q4 2022.
  • 3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.

Based on Baird Financial Group's 13F filing for Q2 2026, filed 12 Aug 2026.